Diana L. Linden. Review of 'Modernism for the Masses: Painters, Politics, and Public Murals in 1930s New York' by Jody Patterson

Autor: Diana Linden

Publikováno v: caa.reviews.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::71a4a8d25acb6bcf69bb3d77f9df92f2
https://doi.org/10.3202/caa.reviews.2021.25

MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma

Autor: Pascal Wolter, Marianne Frostvik Stolt, Rosalyn Jewell, Johan Hansson, Carolina Johansson, Christer Lindholm, Joost van den Oord, Ulrika Stierner, Diana Linden, Christy Walker, Suzanne Egyhazi Brage, Rainer Tuominen, Helen Snowden, Julia Newton-Bishop, Hemming Johansson

Publikováno v: International Journal of Cancer. 136:2844-2853

To investigate the predictive and prognostic value of O(6) -methylguanine DNA methyltransferase (MGMT) inactivation by analyses of promoter methylation in pretreatment tumor biopsies from patients with cutaneous melanoma treated with dacarbazine (DTI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ee8ac4e5314a9d14ddb3bb182bdda303
https://doi.org/10.1002/ijc.29332

Lack of Cytoplasmic ERK Activation Is an Independent Adverse Prognostic Factor in Primary Cutaneous Melanoma

Autor: Johan Hansson, Diana Linden, Suzanne Egyhazi, Bo Nilsson, Doris Kröckel, Braslav Jovanovic

Publikováno v: Journal of Investigative Dermatology. 128(11):2696-2704

The aim of this study was to estimate the impact on survival of NRAS and BRAF mutations and activation of Akt and extracellular signal-regulated kinase (ERK) in primary melanomas. A cohort of 57 primary cutaneous T1-2 melanoma tumors was analyzed. Mu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b75030d716aff40f66b904bfe5f7a8

A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL)

Autor: Harland, M, Goldstein, Am, Kukalizch, K, Taylor, C, Hogg, D, Puig, S, Badenas, C, Gruis, N, TER HUURNE, J, Bergman, W, Hayward, Nk, Stark, M, Tsao, H, Tucker, Ma, Landi, Mt, Bianchi, Giovanna, Ghiorzo, Paola, Kanetsky, Pa, Elder, D, Mann, Gj, Holland, Ea, Bishop, Dt, NEWTON BISHOP, J, Malvehy, J., Badenas, C., Cervera, R., Francisco, Cuellar, Rosa, Marti, JOAN BRUNET VIDAL, Guang, Yang, Nicholas, Martin, David, Whiteman, Adele, Green, Joanne, Aitken, Paola, Minghetti, Michela, Mantelli, Pastorino, Lorenza, Nasti, Sabina, Gargiulo, Sara, Sara, Gliori, Sushila, Mistry, JULIETTE RERSON MOOR, Wilma, Bergman, TER HUURNE, JEANET A. C., CLASINE VAN DER DRIFT, LENY VAN MOURIK, COBY OUT LUITING, FRANS VAN NIEUWPOORT, Valerie, Chaudru, Agnes, Chompret, Caroline, Kanengiesser, Michel, J. L., Grange, F., Sassolas, B., Limacher, J. M., Couillet, D., Truchetet, F., Cesarini, J. P., Boitier, F., CHEVRANT BRETON, J., Lasset, C., Longy, M., Joly, P., BASSET SEGUIN, N., Lesimple, T., Dugast, C., Michael, Ming, PATRICIA VAN BELLE, Anton, Platz, Suzanne, Egyhazi, Rainer, Tuominen, Diana, Linden, Helen, Schmid, Alon, Scope, Felix, Pavlotsky, Eitan, Friedman, Mark, Eliason

CDKN2A is the major melanoma susceptibility gene so far identified, but only 40% of three or more case families have identified mutations. A comparison of mutation detection rates was carried out by "blind" exchange of samples across GenoMEL, the Mel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e469e193a66e631a943aac0b0395b78
http://hdl.handle.net/11567/273207

High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL

Autor: Nicholas K. Hayward, Hensin Tsao, Mark J. Eliason, Suzanne Egyhazi, Paola Minghetti, Paola Ghiorzo, Alisa M. Goldstein, Julie Lang, Juliette Randerson-Moor, Nicole Basset-Seguin, Clasine van der Drift, D. Timothy Bishop, Nicholas G. Martin, Michel Longy, Guang Yang, Sabina Nasti, Adèle C. Green, Valérie Chaudru, Donato Calista, Sara Gargiulo, Florent Grange, Francisco Cuellar, Linda Whitaker, Joseph Malvehy, Esther Azizi, Richard F. Kefford, David E. Elder, Håkan Olsson, Nelleke A. Gruis, Joan Anton Puig-Butille, David W. Hogg, Margaret A. Tucker, Sushila Mistry, Wilma Bergman, Johan Westerdahl, Christian Ingvar, J. P. Cesarini, Jacqueline Chevrant-Breton, Leny van Mourik, Michela Mantelli, Arupa Ganguly, Jean -Marc Limacher, F. Truchetet, Maria Teresa Landi, Kristin B. Niendorf, Elizabeth A. Holland, Anna Måsbäck, Graham J. Mann, Agnès Chompret, Felix Pavlotsky, Veronica Magnusson, Anton Platz, Joanne F. Aitken, Brigitte Bressac-de Paillerets, Michael Ming, Marie-Françoise Avril, F. Boitier, J. L. Michel, May Chan, R. Cervera, Helen Schmid, Johan Hansson, Rosa M. Martí, Florence Demenais, Celia Badenas, Eitan Friedman, David C. Whiteman, Catherine Dugast, Rainer Tuominen, Lorenza Pastorino, D. Couillet, Emanuel Yakobson, T. Lesimple, Åke Borg, Pascal Joly, Julia A. Newton Bishop, Coby Out-Luiting, Peter A. Kanetsky, Caroline Kanengiesser, Sara Gliori, Diana Linden, Joan Brunet-Vidal, Christine Lasset, William Bruno, Susana Puig, Lisa A. Cannon Albright, Frans A. van Nieuwpoort, Alon Scope, Mitchell S. Stark, Giovanna Bianchi-Scarrà, B. Sassolas, Patricia Van Belle, Elizabeth M. Gillanders, Mark Harland, Jeanet A.C. ter Huurne, Rona M. MacKie, Femke A. de Snoo, Sancy A. Leachman, Jane M. Palmer

Publikováno v: Cancer research. 66(20)

GenoMEL, comprising major familial melanoma research groups from North America, Europe, Asia, and Australia has created the largest familial melanoma sample yet available to characterize mutations in the high-risk melanoma susceptibility genes CDKN2A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e4fa0860aa1b2466b099993058f1ff6
https://pubmed.ncbi.nlm.nih.gov/17047042